Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7MF1 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
| 7MJH | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 | Spike glycoprotein, VH ab8 |
| 7MMO | P0DTC2 | LY-CoV1404 neutralizing antibody against SARS-CoV-2 | |
| 6YLA | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab | |
| 7A92 | P0DTC2 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) | Spike glycoprotein |
| 7BEH | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab | |
| 7BEK | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 2) | |
| 7BEL | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-88 and COVOX-45 Fabs | |
| 7CHS | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD | |
| 7CWL | P0DTC2 | SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state | Spike glycoprotein, Fab P17 heavy chain, Fab P17 light chain |
| 7CYP | P0DTC2 | Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27 | |
| 7DJZ | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab | |
| 7DX3 | P0DTC2 | S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound) | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
| 7EB3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3 | |
| 7EH5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15 and RBD-chAb45 | |
| 7KE4 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class) | Spike glycoprotein |
| 7KE6 | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | Spike glycoprotein |
| 7KE9 | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification) | Spike glycoprotein |
| 7KKL | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody mNb6 |
| 7L4Z | P0DTC2 | Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide | |
| 7L7E | P0DTC2 | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 | |
| 7LAA | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 | |
| 7LSS | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 | |
| 7MJG | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain | Spike glycoprotein |
| 7N0G | P0DTC2 | CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) | |
| 7FEM | P0DTC2 | SARS-CoV-2 B.1.1.7 S-ACE2 complex | |
| 7FET | P0DTC2 | SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer | |
| 7N4I | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
| 7N4J | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
| 7N4M | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
| 7PRY | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with COVOX-45 and beta-6 Fabs | |
| 7PRZ | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-22 Fabs | |
| 7PS0 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with beta-24 Fabs | |
| 7PS1 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-27 Fab | |
| 7PS2 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-29 and Beta-53 Fabs | |
| 7PS4 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-38 | |
| 7PS5 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-47 Fab | |
| 7PS6 | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in complex with Beta-44 and Beta-54 Fabs | |
| 7Q6E | P0DTC2 | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
| 7Q9F | P0DTC2 | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9G | P0DTC2 | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9I | P0DTC2 | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9J | P0DTC2 | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9K | P0DTC2 | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9M | P0DTC2 | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9P | P0DTC2 | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7RPV | P0DTC2 | Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD | |
| 7SN2 | P0DTC2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
| 7SN3 | P0DTC2 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
| 7E9T | P0DTC2 | Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike |
